Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ocular Motility Disorders | 1 | 2023 | 43 | 0.880 |
Why?
|
| Strabismus | 1 | 2023 | 51 | 0.880 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2007 | 12 | 0.280 |
Why?
|
| Cranial Nerve Diseases | 1 | 2007 | 77 | 0.260 |
Why?
|
| Acetazolamide | 1 | 2023 | 34 | 0.230 |
Why?
|
| Eye Movements | 1 | 2023 | 78 | 0.220 |
Why?
|
| Calcium Channels | 1 | 2023 | 214 | 0.200 |
Why?
|
| Ataxia | 1 | 2023 | 182 | 0.200 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 9 | 0.200 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 51 | 0.190 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 66 | 0.170 |
Why?
|
| Myasthenia Gravis | 1 | 2021 | 106 | 0.170 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 28 | 0.160 |
Why?
|
| Seizures | 1 | 2023 | 997 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 461 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 376 | 0.130 |
Why?
|
| Infant | 3 | 2023 | 14045 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 3435 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2021 | 2923 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 2112 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 5775 | 0.070 |
Why?
|
| Facial Paralysis | 1 | 2007 | 57 | 0.070 |
Why?
|
| Deafness | 1 | 2007 | 91 | 0.070 |
Why?
|
| Mutation | 2 | 2021 | 15904 | 0.060 |
Why?
|
| Male | 5 | 2023 | 128484 | 0.050 |
Why?
|
| Pyridostigmine Bromide | 1 | 2021 | 13 | 0.050 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 6 | 0.050 |
Why?
|
| Adolescent | 4 | 2021 | 32784 | 0.050 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2020 | 25 | 0.050 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.050 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 23 | 0.050 |
Why?
|
| Neural Conduction | 1 | 2020 | 109 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2021 | 136 | 0.050 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 62 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 157 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 233 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 115 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 86 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 396 | 0.040 |
Why?
|
| Humans | 7 | 2023 | 271093 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2021 | 17095 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 334 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 6503 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 114 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 126 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 1034 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 261 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 614 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 9479 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 562 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 338 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1098 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 1197 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 1247 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1176 | 0.030 |
Why?
|
| Child | 3 | 2021 | 30596 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 1437 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1576 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1249 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2571 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3488 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 39951 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 2163 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 2597 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 2359 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 5458 | 0.020 |
Why?
|
| Female | 4 | 2021 | 149120 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 7900 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 2085 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 4104 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 6868 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 2617 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 4205 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8709 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 4642 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 22293 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 33808 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 82174 | 0.010 |
Why?
|